Skip to main content
Erschienen in: Gastro-News 6/2019

04.12.2019 | Rektumkarzinom | zertifizierte fortbildung

Diagnostik, multimodales Vorgehen und Chirurgie

Therapie des Rektumkarzinoms — ein Update

verfasst von: Dr. med. Philipp-Alexander Neumann, Dr. med. Dr. Ulrich Nitsche, Ph.D., Dr. med. Thomas Vogel, Prof. Dr. med. Helmut Friess, PD Dr. med. Dirk Wilhelm

Erschienen in: Gastro-News | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Dank optimierter chirurgischer und multimodaler Therapiekonzepte konnte die Prognose beim Rektumkarzinom über die vergangenen Jahrzehnte stark verbessert werden. Lesen Sie im Folgenden, was sich im Hinblick auf Diagnostik, Chirurgie und (Neo-)Adjuvanz getan hat. Diskutiert werden zudem der Watch-and-Wait-Ansatz nach kompletter Remission und Maßnahmen zur Senkung der Anastomoseninsuffizienzrate.
Literatur
1.
Zurück zum Zitat Lirici MM, Huscher CG: Techniques and technology evolution of rectal cancer surgery: a history of more than a hundred years. Minimally invasive therapy & allied technologies: MITAT: official journal of the Society for Minimally Invasive Therapy 2016, 25(5):226–233.CrossRef Lirici MM, Huscher CG: Techniques and technology evolution of rectal cancer surgery: a history of more than a hundred years. Minimally invasive therapy & allied technologies: MITAT: official journal of the Society for Minimally Invasive Therapy 2016, 25(5):226–233.CrossRef
2.
Zurück zum Zitat Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T et al.: Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison. British journal of cancer 2018. Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T et al.: Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison. British journal of cancer 2018.
3.
Zurück zum Zitat Draeger T, Volkel V, Gerken M, Klinkhammer-Schalke M, Furst A: Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection: a high-quality population-based analysis in a Southern German district. Surgical endoscopy 2018. Draeger T, Volkel V, Gerken M, Klinkhammer-Schalke M, Furst A: Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection: a high-quality population-based analysis in a Southern German district. Surgical endoscopy 2018.
4.
Zurück zum Zitat Nienhuser H, Heger P, Schmitz R, Kulu Y, Diener MK, Klose J, Schneider M, Muller-Stich BP, Ulrich A, Buchler MW et al.: Short- and Long-Term Oncological Outcome After Rectal Cancer Surgery: a Systematic Review and Meta-Analysis Comparing Open Versus Laparoscopic Rectal Cancer Surgery. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 2018, 22(8):1418–1433.CrossRef Nienhuser H, Heger P, Schmitz R, Kulu Y, Diener MK, Klose J, Schneider M, Muller-Stich BP, Ulrich A, Buchler MW et al.: Short- and Long-Term Oncological Outcome After Rectal Cancer Surgery: a Systematic Review and Meta-Analysis Comparing Open Versus Laparoscopic Rectal Cancer Surgery. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 2018, 22(8):1418–1433.CrossRef
5.
Zurück zum Zitat Vennix S, Pelzers L, Bouvy N, Beets GL, Pierie JP, Wiggers T, Breukink S: Laparoscopic versus open total mesorectal excision for rectal cancer. The Cochrane database of systematic reviews 2014(4):Cd005200. Vennix S, Pelzers L, Bouvy N, Beets GL, Pierie JP, Wiggers T, Breukink S: Laparoscopic versus open total mesorectal excision for rectal cancer. The Cochrane database of systematic reviews 2014(4):Cd005200.
6.
Zurück zum Zitat Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS et al.: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet (London, England) 2009, 373(9666):811–820.CrossRef Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS et al.: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet (London, England) 2009, 373(9666):811–820.CrossRef
7.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. The New England journal of medicine 2004, 351(17):1731–1740.PubMedCrossRef Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. The New England journal of medicine 2004, 351(17):1731–1740.PubMedCrossRef
8.
Zurück zum Zitat Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O’Callaghan C, Myint AS, Bessell E, Thompson LC et al.: Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet (London, England) 2009, 373(9666):821–828.CrossRef Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O’Callaghan C, Myint AS, Bessell E, Thompson LC et al.: Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet (London, England) 2009, 373(9666):821–828.CrossRef
9.
Zurück zum Zitat Hofheinz RD, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT, Muller L, Link H, Moehler M, Kettner E et al.: Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. The Lancet Oncology 2012, 13(6):579–588.PubMedCrossRef Hofheinz RD, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT, Muller L, Link H, Moehler M, Kettner E et al.: Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. The Lancet Oncology 2012, 13(6):579–588.PubMedCrossRef
10.
Zurück zum Zitat O’Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, Pitot HC, Shields AF, Landry JC, Ryan DP et al.: Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2014, 32(18):1927–1934.CrossRef O’Connell MJ, Colangelo LH, Beart RW, Petrelli NJ, Allegra CJ, Sharif S, Pitot HC, Shields AF, Landry JC, Ryan DP et al.: Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2014, 32(18):1927–1934.CrossRef
11.
Zurück zum Zitat Cedermark B, Dahlberg M, Glimelius B, Pahlman L, Rutqvist LE, Wilking N: Improved survival with preoperative radiotherapy in resectable rectal cancer. The New England journal of medicine 1997, 336(14):980–987.PubMedCrossRef Cedermark B, Dahlberg M, Glimelius B, Pahlman L, Rutqvist LE, Wilking N: Improved survival with preoperative radiotherapy in resectable rectal cancer. The New England journal of medicine 1997, 336(14):980–987.PubMedCrossRef
12.
Zurück zum Zitat Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. The New England journal of medicine 2001, 345(9):638–646.PubMedCrossRef Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. The New England journal of medicine 2001, 345(9):638–646.PubMedCrossRef
13.
Zurück zum Zitat Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, Ackland SP, Schache D, McClure B, McLachlan SA et al.: Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2012, 30(31):3827–3833.CrossRef Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, Ackland SP, Schache D, McClure B, McLachlan SA et al.: Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2012, 30(31):3827–3833.CrossRef
14.
Zurück zum Zitat Wang L, Li ZY, Li ZW, Li YH, Sun YS, Ji JF, Gu J, Cai Y: Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer. Diseases of the colon and rectum 2015, 58(2):186–192.PubMedCrossRef Wang L, Li ZY, Li ZW, Li YH, Sun YS, Ji JF, Gu J, Cai Y: Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer. Diseases of the colon and rectum 2015, 58(2):186–192.PubMedCrossRef
15.
Zurück zum Zitat Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP: Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. International journal of radiation oncology, biology, physics 1998, 42(1):51–57.PubMedCrossRef Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP: Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. International journal of radiation oncology, biology, physics 1998, 42(1):51–57.PubMedCrossRef
16.
Zurück zum Zitat Erlandsson J, Lorinc E, Ahlberg M, Pettersson D, Holm T, Glimelius B, Martling A: Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2019, 135:178–186.CrossRef Erlandsson J, Lorinc E, Ahlberg M, Pettersson D, Holm T, Glimelius B, Martling A: Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2019, 135:178–186.CrossRef
17.
Zurück zum Zitat Birgisson H, Pahlman L, Gunnarsson U, Glimelius B: Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2005, 23(34):8697–8705.CrossRef Birgisson H, Pahlman L, Gunnarsson U, Glimelius B: Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2005, 23(34):8697–8705.CrossRef
18.
Zurück zum Zitat Allegra CJ, Yothers G, O’Connell MJ, Beart RW, Wozniak TF, Pitot HC, Shields AF, Landry JC, Ryan DP, Arora A et al.: Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial. Journal of the National Cancer Institute 2015, 107(11). Allegra CJ, Yothers G, O’Connell MJ, Beart RW, Wozniak TF, Pitot HC, Shields AF, Landry JC, Ryan DP, Arora A et al.: Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial. Journal of the National Cancer Institute 2015, 107(11).
19.
Zurück zum Zitat Azria D, Doyen J, Jarlier M, Martel-Lafay I, Hennequin C, Etienne P, Vendrely V, Francois E, de La Roche G, Bouche O et al.: Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer. Annals of oncology: official journal of the European Society for Medical Oncology 2017, 28(10):2436–2442.CrossRef Azria D, Doyen J, Jarlier M, Martel-Lafay I, Hennequin C, Etienne P, Vendrely V, Francois E, de La Roche G, Bouche O et al.: Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer. Annals of oncology: official journal of the European Society for Medical Oncology 2017, 28(10):2436–2442.CrossRef
20.
Zurück zum Zitat Huttner FJ, Probst P, Kalkum E, Hackbusch M, Jensen K, Ulrich A, Debus J, Jager D, Diener MK: Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis. Journal of the National Cancer Institute 2019, 111(9):887–902.CrossRef Huttner FJ, Probst P, Kalkum E, Hackbusch M, Jensen K, Ulrich A, Debus J, Jager D, Diener MK: Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis. Journal of the National Cancer Institute 2019, 111(9):887–902.CrossRef
21.
Zurück zum Zitat Fu XL, Fang Z, Shu LH, Tao GQ, Wang JQ, Rui ZL, Zhang YJ, Tian ZQ: Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer. Oncotarget 2017, 8(21):34340–34351.PubMedPubMedCentral Fu XL, Fang Z, Shu LH, Tao GQ, Wang JQ, Rui ZL, Zhang YJ, Tian ZQ: Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer. Oncotarget 2017, 8(21):34340–34351.PubMedPubMedCentral
22.
Zurück zum Zitat Jalil O, Claydon L, Arulampalam T: Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer. Journal of gastrointestinal cancer 2015, 46(3):219–236.PubMedCrossRef Jalil O, Claydon L, Arulampalam T: Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer. Journal of gastrointestinal cancer 2015, 46(3):219–236.PubMedCrossRef
23.
Zurück zum Zitat Nishimura J, Hasegawa J, Kato T, Yoshioka S, Noura S, Kagawa Y, Yasui M, Ikenaga M, Murata K, Hata T et al.: Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer. Cancer chemotherapy and pharmacology 2018. Nishimura J, Hasegawa J, Kato T, Yoshioka S, Noura S, Kagawa Y, Yasui M, Ikenaga M, Murata K, Hata T et al.: Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer. Cancer chemotherapy and pharmacology 2018.
24.
Zurück zum Zitat Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR et al.: Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. The Lancet Oncology 2015, 16(8):957–966.PubMedPubMedCentralCrossRef Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR et al.: Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. The Lancet Oncology 2015, 16(8):957–966.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Petrelli F, Trevisan F, Cabiddu M, Sgroi G, Bruschieri L, Rausa E, Ghidini M, Turati L: Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes. Annals of surgery 2019. Petrelli F, Trevisan F, Cabiddu M, Sgroi G, Bruschieri L, Rausa E, Ghidini M, Turati L: Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes. Annals of surgery 2019.
26.
Zurück zum Zitat Fokas E, Allgauer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL et al.: Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2019:Jco1900308. Fokas E, Allgauer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL et al.: Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2019:Jco1900308.
27.
Zurück zum Zitat Appelt AL, Ploen J, Harling H, Jensen FS, Jensen LH, Jorgensen JC, Lindebjerg J, Rafaelsen SR, Jakobsen A: High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. The Lancet Oncology 2015, 16(8):919–927.PubMedCrossRef Appelt AL, Ploen J, Harling H, Jensen FS, Jensen LH, Jorgensen JC, Lindebjerg J, Rafaelsen SR, Jakobsen A: High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. The Lancet Oncology 2015, 16(8):919–927.PubMedCrossRef
28.
Zurück zum Zitat Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ, Bardet E, Beny A, Ollier JC, Bolla M et al.: Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. The Lancet Oncology 2014, 15(2):184–190.PubMedCrossRef Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ, Bardet E, Beny A, Ollier JC, Bolla M et al.: Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. The Lancet Oncology 2014, 15(2):184–190.PubMedCrossRef
29.
Zurück zum Zitat Zhao L, Liu R, Zhang Z, Li T, Li F, Liu H, Li G: Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 2016, 18(8):763–772.CrossRef Zhao L, Liu R, Zhang Z, Li T, Li F, Liu H, Li G: Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 2016, 18(8):763–772.CrossRef
30.
Zurück zum Zitat Benson AB, 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF et al.: Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN 2018, 16(7):874–901.PubMedCrossRef Benson AB, 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF et al.: Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN 2018, 16(7):874–901.PubMedCrossRef
31.
Zurück zum Zitat Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Tekkis P, Pedersen BG et al.: Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study. Annals of surgery 2016, 263(4):751–760.PubMedCrossRef Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Tekkis P, Pedersen BG et al.: Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study. Annals of surgery 2016, 263(4):751–760.PubMedCrossRef
32.
Zurück zum Zitat Taylor FG, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, Sebag-Montefiore D, Tekkis P, Brown G: Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2014, 32(1):34–43.CrossRef Taylor FG, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, Sebag-Montefiore D, Tekkis P, Brown G: Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2014, 32(1):34–43.CrossRef
33.
Zurück zum Zitat Yu XP, Wen L, Hou J, Bi F, Hu P, Wang H, Wang W: Discrimination between Metastatic and Nonmetastatic Mesorectal Lymph Nodes in Rectal Cancer Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging. Academic radiology 2016, 23(4):479–485.PubMedCrossRef Yu XP, Wen L, Hou J, Bi F, Hu P, Wang H, Wang W: Discrimination between Metastatic and Nonmetastatic Mesorectal Lymph Nodes in Rectal Cancer Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging. Academic radiology 2016, 23(4):479–485.PubMedCrossRef
34.
Zurück zum Zitat Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K: Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. International journal of radiation oncology, biology, physics 2012, 82(2):863–870.PubMedCrossRef Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K: Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. International journal of radiation oncology, biology, physics 2012, 82(2):863–870.PubMedCrossRef
35.
Zurück zum Zitat Chen YG, Chen MQ, Guo YY, Li SC, Wu JX, Xu BH: Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. PloS one 2016, 11(4):e0153944.PubMedPubMedCentralCrossRef Chen YG, Chen MQ, Guo YY, Li SC, Wu JX, Xu BH: Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. PloS one 2016, 11(4):e0153944.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Ashraf S, Hompes R, Slater A, Lindsey I, Bach S, Mortensen NJ, Cunningham C: A critical appraisal of endorectal ultrasound and transanal endoscopic microsurgery and decision-making in early rectal cancer. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 2012, 14(7):821–826.CrossRef Ashraf S, Hompes R, Slater A, Lindsey I, Bach S, Mortensen NJ, Cunningham C: A critical appraisal of endorectal ultrasound and transanal endoscopic microsurgery and decision-making in early rectal cancer. Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland 2012, 14(7):821–826.CrossRef
37.
Zurück zum Zitat Marone P, de Bellis M, D’Angelo V, Delrio P, Passananti V, Di Girolamo E, Rossi GB, Rega D, Tracey MC, Tempesta AM: Role of endoscopic ultrasonography in the loco-regional staging of patients with rectal cancer. World journal of gastrointestinal endoscopy 2015, 7(7):688–701.PubMedPubMedCentralCrossRef Marone P, de Bellis M, D’Angelo V, Delrio P, Passananti V, Di Girolamo E, Rossi GB, Rega D, Tracey MC, Tempesta AM: Role of endoscopic ultrasonography in the loco-regional staging of patients with rectal cancer. World journal of gastrointestinal endoscopy 2015, 7(7):688–701.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Wolberink SV, Beets-Tan RG, de Haas-Kock DF, Span MM, van de Jagt EJ, van de Velde CJ, Wiggers T: Conventional CT for the prediction of an involved circumferential resection margin in primary rectal cancer. Digestive diseases (Basel, Switzerland) 2007, 25(1):80–85.CrossRef Wolberink SV, Beets-Tan RG, de Haas-Kock DF, Span MM, van de Jagt EJ, van de Velde CJ, Wiggers T: Conventional CT for the prediction of an involved circumferential resection margin in primary rectal cancer. Digestive diseases (Basel, Switzerland) 2007, 25(1):80–85.CrossRef
39.
Zurück zum Zitat Kitz J, Fokas E, Beissbarth T, Strobel P, Wittekind C, Hartmann A, Ruschoff J, Papadopoulos T, Rosler E, Ortloff-Kittredge P et al.: Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. JAMA surgery 2018, 153(8):e181607.PubMedPubMedCentralCrossRef Kitz J, Fokas E, Beissbarth T, Strobel P, Wittekind C, Hartmann A, Ruschoff J, Papadopoulos T, Rosler E, Ortloff-Kittredge P et al.: Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. JAMA surgery 2018, 153(8):e181607.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Hwang MR, Park JW, Park S, Yoon H, Kim DY, Chang HJ, Kim SY, Park SC, Choi HS, Oh JH et al.: Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy. Annals of surgical oncology 2014, 21(4):1345–1351.PubMedCrossRef Hwang MR, Park JW, Park S, Yoon H, Kim DY, Chang HJ, Kim SY, Park SC, Choi HS, Oh JH et al.: Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy. Annals of surgical oncology 2014, 21(4):1345–1351.PubMedCrossRef
41.
Zurück zum Zitat Nagtegaal ID, Quirke P: What is the role for the circumferential margin in the modern treatment of rectal cancer? Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008, 26(2):303–312.CrossRef Nagtegaal ID, Quirke P: What is the role for the circumferential margin in the modern treatment of rectal cancer? Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008, 26(2):303–312.CrossRef
42.
Zurück zum Zitat Baxter NN, Garcia-Aguilar J: Organ preservation for rectal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2007, 25(8):1014–1020.CrossRef Baxter NN, Garcia-Aguilar J: Organ preservation for rectal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2007, 25(8):1014–1020.CrossRef
43.
Zurück zum Zitat Schmitz KJ, Chmelar C, Berg E, Schmid KW: [Pathological work-up of rectal cancer following partial/total mesorectal excision]. Der Pathologe 2011, 32(4):321–329.PubMedCrossRef Schmitz KJ, Chmelar C, Berg E, Schmid KW: [Pathological work-up of rectal cancer following partial/total mesorectal excision]. Der Pathologe 2011, 32(4):321–329.PubMedCrossRef
44.
Zurück zum Zitat Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH: Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. The American journal of surgical pathology 2002, 26(3):350–357.PubMedCrossRef Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH: Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. The American journal of surgical pathology 2002, 26(3):350–357.PubMedCrossRef
45.
Zurück zum Zitat Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J: Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. Jama 2015, 314(13):1356–1363.PubMedCrossRef Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J: Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer: The ALaCaRT Randomized Clinical Trial. Jama 2015, 314(13):1356–1363.PubMedCrossRef
46.
Zurück zum Zitat Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR, Jr., Maun D, Chang G, Herline A et al.: Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. Jama 2015, 314(13):1346–1355.PubMedPubMedCentralCrossRef Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR, Jr., Maun D, Chang G, Herline A et al.: Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. Jama 2015, 314(13):1346–1355.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, Peters WR, Jr., Maun DC, Chang GJ, Herline A et al.: Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial. Annals of surgery 2018. Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, Peters WR, Jr., Maun DC, Chang GJ, Herline A et al.: Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial. Annals of surgery 2018.
48.
Zurück zum Zitat Creavin B, Kelly ME, Ryan E, Winter DC: Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer. The British journal of surgery 2017, 104(12):1609–1619.PubMedCrossRef Creavin B, Kelly ME, Ryan E, Winter DC: Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer. The British journal of surgery 2017, 104(12):1609–1619.PubMedCrossRef
49.
Zurück zum Zitat Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J, Angenete E et al.: A randomized trial of laparoscopic versus open surgery for rectal cancer. The New England journal of medicine 2015, 372(14):1324–1332.PubMedCrossRef Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J, Angenete E et al.: A randomized trial of laparoscopic versus open surgery for rectal cancer. The New England journal of medicine 2015, 372(14):1324–1332.PubMedCrossRef
50.
Zurück zum Zitat Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, Choi HS, Kim DW, Chang HJ, Kim DY et al.: Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. The Lancet Oncology 2014, 15(7):767–774.PubMedCrossRef Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, Choi HS, Kim DW, Chang HJ, Kim DY et al.: Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. The Lancet Oncology 2014, 15(7):767–774.PubMedCrossRef
51.
Zurück zum Zitat Ruppert R, Junginger T, Ptok H, Strassburg J, Maurer CA, Brosi P, Sauer J, Baral J, Kreis M, Wollschlaeger D et al.: Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial. The British journal of surgery 2018. Ruppert R, Junginger T, Ptok H, Strassburg J, Maurer CA, Brosi P, Sauer J, Baral J, Kreis M, Wollschlaeger D et al.: Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial. The British journal of surgery 2018.
52.
Zurück zum Zitat Mathis KL, Larson DW, Dozois EJ, Cima RR, Huebner M, Haddock MG, Wolff BG, Nelson H, Pemberton JH: Outcomes following surgery without radiotherapy for rectal cancer. The British journal of surgery 2012, 99(1):137–143.PubMedCrossRef Mathis KL, Larson DW, Dozois EJ, Cima RR, Huebner M, Haddock MG, Wolff BG, Nelson H, Pemberton JH: Outcomes following surgery without radiotherapy for rectal cancer. The British journal of surgery 2012, 99(1):137–143.PubMedCrossRef
53.
Zurück zum Zitat Volkel V, Draeger T, Gerken M, Klinkhammer-Schalke M, Furst A: Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district. Surgical endoscopy 2018. Volkel V, Draeger T, Gerken M, Klinkhammer-Schalke M, Furst A: Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district. Surgical endoscopy 2018.
54.
Zurück zum Zitat Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M et al.: Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Annals of surgery 2017, 266(2):201–207.PubMedCrossRef Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M et al.: Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Annals of surgery 2017, 266(2):201–207.PubMedCrossRef
55.
Zurück zum Zitat Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T et al.: Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. The Lancet Oncology 2012, 13(6):616–621.PubMedCrossRef Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa M, Yamaguchi T et al.: Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. The Lancet Oncology 2012, 13(6):616–621.PubMedCrossRef
56.
Zurück zum Zitat Kusters M, Slater A, Muirhead R, Hompes R, Guy RJ, Jones OM, George BD, Lindsey I, Mortensen NJ, Cunningham C: What To Do With Lateral Nodal Disease in Low Locally Advanced Rectal Cancer? A Call for Further Reflection and Research. Diseases of the colon and rectum 2017, 60(6):577–585.PubMedCrossRef Kusters M, Slater A, Muirhead R, Hompes R, Guy RJ, Jones OM, George BD, Lindsey I, Mortensen NJ, Cunningham C: What To Do With Lateral Nodal Disease in Low Locally Advanced Rectal Cancer? A Call for Further Reflection and Research. Diseases of the colon and rectum 2017, 60(6):577–585.PubMedCrossRef
57.
Zurück zum Zitat Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K et al.: Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. JAMA surgery 2019:e192172. Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K et al.: Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. JAMA surgery 2019:e192172.
58.
Zurück zum Zitat Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C, Tuynman JB, Lacy AM, Hanna GB, Bonjer HJ: COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surgical endoscopy 2016, 30(8):3210–3215.PubMedCrossRef Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C, Tuynman JB, Lacy AM, Hanna GB, Bonjer HJ: COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surgical endoscopy 2016, 30(8):3210–3215.PubMedCrossRef
59.
Zurück zum Zitat Rouanet P, Bertrand MM, Jarlier M, Mourregot A, Traore D, Taoum C, de Forges H, Colombo PE: Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives. Annals of surgical oncology 2018. Rouanet P, Bertrand MM, Jarlier M, Mourregot A, Traore D, Taoum C, de Forges H, Colombo PE: Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives. Annals of surgical oncology 2018.
60.
Zurück zum Zitat Prete FP, Pezzolla A, Prete F, Testini M, Marzaioli R, Patriti A, Jimenez-Rodriguez RM, Gurrado A, Strippoli GFM: Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Annals of surgery 2018, 267(6):1034–1046.PubMedCrossRef Prete FP, Pezzolla A, Prete F, Testini M, Marzaioli R, Patriti A, Jimenez-Rodriguez RM, Gurrado A, Strippoli GFM: Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Annals of surgery 2018, 267(6):1034–1046.PubMedCrossRef
61.
Zurück zum Zitat Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, Liu H, Wang Z: Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC cancer 2016, 16:380.PubMedPubMedCentralCrossRef Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, Liu H, Wang Z: Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC cancer 2016, 16:380.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Xu W, Xu Z, Cheng H, Ying J, Cheng F, Xu W, Cao J, Luo J: Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2016, 42(12):1841–1850.CrossRef Xu W, Xu Z, Cheng H, Ying J, Cheng F, Xu W, Cao J, Luo J: Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2016, 42(12):1841–1850.CrossRef
63.
Zurück zum Zitat Yamaguchi T, Kinugasa Y, Shiomi A, Tomioka H, Kagawa H, Yamakawa Y: Robotic-assisted vs. conventional laparoscopic surgery for rectal cancer: short-term outcomes at a single center. Surgery today 2016, 46(8):957–962.PubMedCrossRef Yamaguchi T, Kinugasa Y, Shiomi A, Tomioka H, Kagawa H, Yamakawa Y: Robotic-assisted vs. conventional laparoscopic surgery for rectal cancer: short-term outcomes at a single center. Surgery today 2016, 46(8):957–962.PubMedCrossRef
64.
Zurück zum Zitat Marks JH, Myers EA, Zeger EL, Denittis AS, Gummadi M, Marks GJ: Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer. Surgical endoscopy 2017, 31(12):5248–5257.PubMedCrossRef Marks JH, Myers EA, Zeger EL, Denittis AS, Gummadi M, Marks GJ: Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer. Surgical endoscopy 2017, 31(12):5248–5257.PubMedCrossRef
65.
Zurück zum Zitat Aubert M, Mege D, Panis Y: Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis. Surgical endoscopy 2019. Aubert M, Mege D, Panis Y: Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis. Surgical endoscopy 2019.
66.
Zurück zum Zitat Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Jr., Silva e Sousa AH, Jr., Campos FG, Kiss DR, Gama-Rodrigues J: Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Annals of surgery 2004, 240(4):711–717; discussion 717–718.PubMedPubMedCentral Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Jr., Silva e Sousa AH, Jr., Campos FG, Kiss DR, Gama-Rodrigues J: Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Annals of surgery 2004, 240(4):711–717; discussion 717–718.PubMedPubMedCentral
67.
Zurück zum Zitat Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD: Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. Journal of the American College of Surgeons 2002, 194(2):131–135; discussion 135–136.PubMedCrossRef Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD: Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. Journal of the American College of Surgeons 2002, 194(2):131–135; discussion 135–136.PubMedCrossRef
68.
Zurück zum Zitat Appelt AL, Vogelius IR, Ploen J, Rafaelsen SR, Lindebjerg J, Havelund BM, Bentzen SM, Jakobsen A: Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost. International journal of radiation oncology, biology, physics 2014, 90(1):110–118.PubMedPubMedCentralCrossRef Appelt AL, Vogelius IR, Ploen J, Rafaelsen SR, Lindebjerg J, Havelund BM, Bentzen SM, Jakobsen A: Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost. International journal of radiation oncology, biology, physics 2014, 90(1):110–118.PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, Guillem JG, Paty PB, Avila K, Garcia-Aguilar J: Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC cancer 2015, 15:767.PubMedPubMedCentralCrossRef Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, Guillem JG, Paty PB, Avila K, Garcia-Aguilar J: Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC cancer 2015, 15:767.PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Lim L, Chao M, Shapiro J, Millar JL, Kipp D, Rezo A, Fong A, Jones IT, McLaughlin S, Gibbs P: Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal. Diseases of the colon and rectum 2007, 50(12):2032–2039.CrossRef Lim L, Chao M, Shapiro J, Millar JL, Kipp D, Rezo A, Fong A, Jones IT, McLaughlin S, Gibbs P: Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal. Diseases of the colon and rectum 2007, 50(12):2032–2039.CrossRef
71.
Zurück zum Zitat Sao Juliao GP, Karagkounis G, Fernandez LM, Habr-Gama A, Vailati BB, Dattani M, Kalady MF, Perez RO: Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time. Annals of surgery 2019. Sao Juliao GP, Karagkounis G, Fernandez LM, Habr-Gama A, Vailati BB, Dattani M, Kalady MF, Perez RO: Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time. Annals of surgery 2019.
72.
Zurück zum Zitat Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, van Dam RM, Jansen RL, Sosef M, Leijtens JW et al.: Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2011, 29(35):4633–4640.CrossRef Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, van Dam RM, Jansen RL, Sosef M, Leijtens JW et al.: Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2011, 29(35):4633–4640.CrossRef
73.
Zurück zum Zitat van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH: Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet (London, England) 2018, 391(10139):2537–2545.CrossRef van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH: Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet (London, England) 2018, 391(10139):2537–2545.CrossRef
74.
Zurück zum Zitat Li J, Li L, Yang L, Yuan J, Lv B, Yao Y, Xing S: Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Oncotarget 2016, 7(28):44857–44870.PubMedPubMedCentral Li J, Li L, Yang L, Yuan J, Lv B, Yao Y, Xing S: Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Oncotarget 2016, 7(28):44857–44870.PubMedPubMedCentral
75.
Zurück zum Zitat Kong JC, Guerra GR, Warrier SK, Ramsay RG, Heriot AG: Outcome and Salvage Surgery Following “Watch and Wait” for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review. Diseases of the colon and rectum 2017, 60(3):335–345.PubMedCrossRef Kong JC, Guerra GR, Warrier SK, Ramsay RG, Heriot AG: Outcome and Salvage Surgery Following “Watch and Wait” for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review. Diseases of the colon and rectum 2017, 60(3):335–345.PubMedCrossRef
76.
Zurück zum Zitat de Campos-Lobato LF, Stocchi L, da Luz Moreira A, Geisler D, Dietz DW, Lavery IC, Fazio VW, Kalady MF: Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Annals of surgical oncology 2011, 18(6):1590–1598.PubMedCrossRef de Campos-Lobato LF, Stocchi L, da Luz Moreira A, Geisler D, Dietz DW, Lavery IC, Fazio VW, Kalady MF: Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Annals of surgical oncology 2011, 18(6):1590–1598.PubMedCrossRef
77.
Zurück zum Zitat Gavioli M, Luppi G, Losi L, Bertolini F, Santantonio M, Falchi AM, D’Amico R, Conte PF, Natalini G: Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Diseases of the colon and rectum 2005, 48(10):1851–1857.CrossRef Gavioli M, Luppi G, Losi L, Bertolini F, Santantonio M, Falchi AM, D’Amico R, Conte PF, Natalini G: Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Diseases of the colon and rectum 2005, 48(10):1851–1857.CrossRef
78.
Zurück zum Zitat Habr-Gama A, Gama-Rodrigues J, Sao Juliao GP, Proscurshim I, Sabbagh C, Lynn PB, Perez RO: Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. International journal of radiation oncology, biology, physics 2014, 88(4):822–828.PubMedCrossRef Habr-Gama A, Gama-Rodrigues J, Sao Juliao GP, Proscurshim I, Sabbagh C, Lynn PB, Perez RO: Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. International journal of radiation oncology, biology, physics 2014, 88(4):822–828.PubMedCrossRef
79.
Zurück zum Zitat Araujo RO, Valadao M, Borges D, Linhares E, de Jesus JP, Ferreira CG, Victorino AP, Vieira FM, Albagli R: Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015, 41(11):1456–1463.CrossRef Araujo RO, Valadao M, Borges D, Linhares E, de Jesus JP, Ferreira CG, Victorino AP, Vieira FM, Albagli R: Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015, 41(11):1456–1463.CrossRef
80.
Zurück zum Zitat Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP et al.: Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. The Lancet Oncology 2016, 17(2):174–183.PubMedCrossRef Renehan AG, Malcomson L, Emsley R, Gollins S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP et al.: Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. The Lancet Oncology 2016, 17(2):174–183.PubMedCrossRef
81.
Zurück zum Zitat Martens MH, van Heeswijk MM, van den Broek JJ, Rao SX, Vandecaveye V, Vliegen RA, Schreurs WH, Beets GL, Lambregts DM, Beets-Tan RG: Prospective, Multicenter Validation Study of Magnetic Resonance Volumetry for Response Assessment After Preoperative Chemoradiation in Rectal Cancer: Can the Results in the Literature be Reproduced? International journal of radiation oncology, biology, physics 2015, 93(5):1005–1014.PubMedCrossRef Martens MH, van Heeswijk MM, van den Broek JJ, Rao SX, Vandecaveye V, Vliegen RA, Schreurs WH, Beets GL, Lambregts DM, Beets-Tan RG: Prospective, Multicenter Validation Study of Magnetic Resonance Volumetry for Response Assessment After Preoperative Chemoradiation in Rectal Cancer: Can the Results in the Literature be Reproduced? International journal of radiation oncology, biology, physics 2015, 93(5):1005–1014.PubMedCrossRef
82.
Zurück zum Zitat Lai CL, Lai MJ, Wu CC, Jao SW, Hsiao CW: Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or “watch and wait”. International journal of colorectal disease 2016, 31(2):413–419.PubMedCrossRef Lai CL, Lai MJ, Wu CC, Jao SW, Hsiao CW: Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or “watch and wait”. International journal of colorectal disease 2016, 31(2):413–419.PubMedCrossRef
83.
Zurück zum Zitat Nahas SC, Rizkallah Nahas CS, Sparapan Marques CF, Ribeiro U, Jr., Cotti GC, Imperiale AR, Capareli FC, Chih Chen AT, Hoff PM, Cecconello I: Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer. Diseases of the colon and rectum 2016, 59(4):255–263.PubMedCrossRef Nahas SC, Rizkallah Nahas CS, Sparapan Marques CF, Ribeiro U, Jr., Cotti GC, Imperiale AR, Capareli FC, Chih Chen AT, Hoff PM, Cecconello I: Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer. Diseases of the colon and rectum 2016, 59(4):255–263.PubMedCrossRef
84.
Zurück zum Zitat Creavin B, Ryan E, Martin ST, Hanly A, O’Connell PR, Sheahan K, Winter DC: Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. British journal of cancer 2017, 116(2):169–174.PubMedCrossRef Creavin B, Ryan E, Martin ST, Hanly A, O’Connell PR, Sheahan K, Winter DC: Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. British journal of cancer 2017, 116(2):169–174.PubMedCrossRef
85.
Zurück zum Zitat Lee S, Ahn B, Lee S: The Relationship Between the Number of Intersections of Staple Lines and Anastomotic Leakage After the Use of a Double Stapling Technique in Laparoscopic Colorectal Surgery. Surgical laparoscopy, endoscopy & percutaneous techniques 2017, 27(4):273–281.CrossRef Lee S, Ahn B, Lee S: The Relationship Between the Number of Intersections of Staple Lines and Anastomotic Leakage After the Use of a Double Stapling Technique in Laparoscopic Colorectal Surgery. Surgical laparoscopy, endoscopy & percutaneous techniques 2017, 27(4):273–281.CrossRef
86.
Zurück zum Zitat Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP: Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Annals of surgery 2017, 266(1):111–117.PubMedCrossRef Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP: Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases. Annals of surgery 2017, 266(1):111–117.PubMedCrossRef
87.
Zurück zum Zitat Klinger AL, Green H, Monlezun DJ, Beck D, Kann B, Vargas HD, Whitlow C, Margolin D: The Role of Bowel Preparation in Colorectal Surgery: Results of the 2012–2015 ACS-NSQIP Data. Annals of surgery 2017. Klinger AL, Green H, Monlezun DJ, Beck D, Kann B, Vargas HD, Whitlow C, Margolin D: The Role of Bowel Preparation in Colorectal Surgery: Results of the 2012–2015 ACS-NSQIP Data. Annals of surgery 2017.
88.
Zurück zum Zitat Kiran RP, Murray AC, Chiuzan C, Estrada D, Forde K: Combined preoperative mechanical bowel preparation with oral antibiotics significantly reduces surgical site infection, anastomotic leak, and ileus after colorectal surgery. Annals of surgery 2015, 262(3):416–425; discussion 423-415.PubMedCrossRef Kiran RP, Murray AC, Chiuzan C, Estrada D, Forde K: Combined preoperative mechanical bowel preparation with oral antibiotics significantly reduces surgical site infection, anastomotic leak, and ileus after colorectal surgery. Annals of surgery 2015, 262(3):416–425; discussion 423-415.PubMedCrossRef
89.
Zurück zum Zitat Roos D, Dijksman LM, Tijssen JG, Gouma DJ, Gerhards MF, Oudemans-van Straaten HM: Systematic review of perioperative selective decontamination of the digestive tract in elective gastrointestinal surgery. The British journal of surgery 2013, 100(12):1579–1588.PubMedCrossRef Roos D, Dijksman LM, Tijssen JG, Gouma DJ, Gerhards MF, Oudemans-van Straaten HM: Systematic review of perioperative selective decontamination of the digestive tract in elective gastrointestinal surgery. The British journal of surgery 2013, 100(12):1579–1588.PubMedCrossRef
90.
Zurück zum Zitat Abis GSA, Stockmann H, Bonjer HJ, van Veenendaal N, van Doorn-Schepens MLM, Budding AE, Wilschut JA, van Egmond M, Oosterling SJ: Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial). The British journal of surgery 2019, 106(4):355–363.PubMedCrossRef Abis GSA, Stockmann H, Bonjer HJ, van Veenendaal N, van Doorn-Schepens MLM, Budding AE, Wilschut JA, van Egmond M, Oosterling SJ: Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial). The British journal of surgery 2019, 106(4):355–363.PubMedCrossRef
91.
Zurück zum Zitat Koskenvuo L, Lehtonen T, Koskensalo S, Rasilainen S, Klintrup K, Ehrlich A, Pinta T, Scheinin T, Sallinen V: Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial. Lancet (London, England) 2019, 394(10201):840–848.CrossRef Koskenvuo L, Lehtonen T, Koskensalo S, Rasilainen S, Klintrup K, Ehrlich A, Pinta T, Scheinin T, Sallinen V: Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial. Lancet (London, England) 2019, 394(10201):840–848.CrossRef
92.
Zurück zum Zitat Gillis C, Buhler K, Bresee L, Carli F, Gramlich L, Culos-Reed N, Sajobi TT, Fenton TR: Effects of Nutritional Prehabilitation, With and Without Exercise, on Outcomes of Patients Who Undergo Colorectal Surgery: A Systematic Review and Meta-analysis. Gastroenterology 2018, 155(2):391–410.e394.PubMedCrossRef Gillis C, Buhler K, Bresee L, Carli F, Gramlich L, Culos-Reed N, Sajobi TT, Fenton TR: Effects of Nutritional Prehabilitation, With and Without Exercise, on Outcomes of Patients Who Undergo Colorectal Surgery: A Systematic Review and Meta-analysis. Gastroenterology 2018, 155(2):391–410.e394.PubMedCrossRef
93.
Zurück zum Zitat Moran J, Guinan E, McCormick P, Larkin J, Mockler D, Hussey J, Moriarty J, Wilson F: The ability of prehabilitation to influence postoperative outcome after intra-abdominal operation: A systematic review and meta-analysis. Surgery 2016, 160(5):1189–1201.PubMedCrossRef Moran J, Guinan E, McCormick P, Larkin J, Mockler D, Hussey J, Moriarty J, Wilson F: The ability of prehabilitation to influence postoperative outcome after intra-abdominal operation: A systematic review and meta-analysis. Surgery 2016, 160(5):1189–1201.PubMedCrossRef
94.
Zurück zum Zitat Huser N, Michalski CW, Erkan M, Schuster T, Rosenberg R, Kleeff J, Friess H: Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Annals of surgery 2008, 248(1):52–60.PubMedCrossRef Huser N, Michalski CW, Erkan M, Schuster T, Rosenberg R, Kleeff J, Friess H: Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Annals of surgery 2008, 248(1):52–60.PubMedCrossRef
95.
Zurück zum Zitat Mrak K, Uranitsch S, Pedross F, Heuberger A, Klingler A, Jagoditsch M, Weihs D, Eberl T, Tschmelitsch J: Diverting ileostomy versus no diversion after low anterior resection for rectal cancer: A prospective, randomized, multicenter trial. Surgery 2016, 159(4):1129–1139.PubMedCrossRef Mrak K, Uranitsch S, Pedross F, Heuberger A, Klingler A, Jagoditsch M, Weihs D, Eberl T, Tschmelitsch J: Diverting ileostomy versus no diversion after low anterior resection for rectal cancer: A prospective, randomized, multicenter trial. Surgery 2016, 159(4):1129–1139.PubMedCrossRef
Metadaten
Titel
Diagnostik, multimodales Vorgehen und Chirurgie
Therapie des Rektumkarzinoms — ein Update
verfasst von
Dr. med. Philipp-Alexander Neumann
Dr. med. Dr. Ulrich Nitsche, Ph.D.
Dr. med. Thomas Vogel
Prof. Dr. med. Helmut Friess
PD Dr. med. Dirk Wilhelm
Publikationsdatum
04.12.2019
Verlag
Springer Medizin
Erschienen in
Gastro-News / Ausgabe 6/2019
Print ISSN: 1869-1005
Elektronische ISSN: 2520-8667
DOI
https://doi.org/10.1007/s15036-019-0488-5

Weitere Artikel der Ausgabe 6/2019

Gastro-News 6/2019 Zur Ausgabe